Insulinoma‐associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts
Histopathology2019Vol. 75(4), pp. 568–577
Citations Over TimeTop 10% of 2019 papers
Iván González, Hsiang‐Chih Lu, Jared A. Sninsky, Chen Yang, Kumar S. Bishnupuri, Brian K. Dieckgraefe, Dengfeng Cao, Deyali Chatterjee
Abstract
The nuclear reactivity and the high sensitivity and specificity of INSM1 make it a preferred neuroendocrine marker. In conclusion, INSM1 can be used as a single first-line marker for primary and metastatic GEP-NEN.
Related Papers
- → Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections(2018)143 cited
- → Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors(2023)15 cited
- Neuroendocrine differentiation in primary Merkel cell carcinoma--possible prognostic significance.(2005)
- → Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast(2021)10 cited
- → The effect of neuroendocrine differentiation on the survival of patients diagnosed with pancreatic ductal adenocarcinoma(2020)